Firms partner with Microsoft to advance DNA data storage

By The Science Advisory Board staff writers

November 13, 2020 -- Twist Bioscience, Illumina, and Western Digital have formed an alliance with Microsoft to advance the field of DNA data storage.

The companies are joining the DNA Data Storage Alliance as founding members. Together, they will create a comprehensive industry roadmap that will achieve interoperability and establish cost-effective commercial archival storage ecosystems. The alliance also plans to develop use cases in various markets and industries as well as to promote DNA storage and to educate the larger storage community on the adoption of this future solution.

The firms estimate that in the coming years many digital businesses will have to switch to new data storage solutions.

DNA data storage can potentially be a long-term storage technology. DNA provides a stable format medium that is durable for thousands of years when properly stored. Additionally, DNA enables cost-effective and rapid duplication. It is dense, with 10 full length digital movies fitting into a volume the size of a single grain of salt, according to the firms. Digital data can be stored on DNA capsules or pellets or encased in glass beads.

Microsoft has collaborated with the University of Washington to develop a fully automated end-to-end system that is capable of storing and retrieving data from DNA.

ImmunoPrecise, Twist collaborate on novel therapeutics
ImmunoPrecise subsidiary Talem Therapeutics and Twist Bioscience will collaborate on the creation of novel therapeutic molecules.
Twist Bioscience finds new SARS-CoV-2 neutralizers
Twist Bioscience has identified immunoglobulin G antibodies and single dose domain VHH nanobodies that have neutralizing effects against SARS-CoV-2.
Illumina's Q2 revenue drops 25%
Illumina's revenue dropped 25% due to the impact of the COVID-19 pandemic on the company's business in the second quarter. The company's net income also...
Illumina launches affordable sequencing kit for labs
Illumina has launched its NovaSeq 6000 v1.5 reagent kit, intended to make genome sequencing more accessible and affordable for labs of all sizes with...
Twist Bioscience, Seismic Bio partner to discover bispecific antibodies
Twist Bioscience and Seismic Bio have formed a partnership to discover and optimize antibodies to high-value immuno-oncology targets.
Takeda, Twist partner on biologics discovery
Twist Bioscience and Takeda Pharmaceutical have formed a partnership for access to Twist's proprietary phage display libraries for the discovery of antibodies...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter